Head-to-head · WeighScore
EllieMD vs No BS RX
The verdict
No BS RX takes it — 82.8/100 to 55/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EllieMD | No BS RX |
|---|---|---|
| WeighScore | 55/100 | 82.8/100 |
| Grade | C | B− |
| Site position | #497 | #25 |
| Semaglutide | GLP-1 program quote required; confirm exact ingredient | $179/mo month-to-month (a separate low-dose program is $140) |
| Tirzepatide | GLP-1/GIP program quote required; confirm exact ingredient | $249/mo month-to-month (a separate low-dose program is $140) |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Site position #497 · C
Strengths
- Offers compounded injection and oral-drop formats
- States payment is refunded when its clinician finds the patient ineligible
Where it loses points
- Public product terminology does not consistently identify the exact active ingredient
- Weight-loss FAQ conflicts with its own statement that compounds are not FDA-approved
- Current all-in price and recurring terms need confirmation
Site position #25 · B−
Strengths
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
- Six programs across four terms are published with no intake and no account
- A sleep program is priced on the same page, including a diagnostic ring study at $33/mo
Where it loses points
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
- The Terms name four pharmacies and no operating company
- State availability is not published, and there is no FDA-approved brand lane
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.